APO Research
Talk to an analyst

APO RESEARCH · REPORT

Venlafaxine Preparations

Compare research editions
View pricing & licenses

Selected research

Industry Research

Venlafaxine Preparations Industry Research Report 2026

28 December 2025135 pages

Choose your research edition.

Industry ResearchVenlafaxine Preparations Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Venlafaxine Preparations Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Venlafaxine Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Venlafaxine Preparations Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Venlafaxine Preparations Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Venlafaxine Preparations market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Venlafaxine Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Venlafaxine Preparations is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Venlafaxine Preparations is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Venlafaxine Preparations include Alembic, Dr. Reddy's Laboratories, Granules, Macleods Pharmaceuticals, Orbion Pharmaceuticals, Pfizer, Teva, Zydus and Beijing Foyou Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Venlafaxine Preparations market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Venlafaxine Preparations Market by Company

Alembic

Dr. Reddy's Laboratories

Granules

Macleods Pharmaceuticals

Orbion Pharmaceuticals

Pfizer

Teva

Zydus

Beijing Foyou Pharma

Changzhou Siyao Pharmaceuticals

Chengdu Brilliant Pharmaceutical

Chengdu Kanghong Pharmaceutical

ApicHope Pharmaceutical

Sinopharm Group

Hainan Herui Pharmaceutical

Hefei Lifeon Pharmaceutical

Luye Pharma

CSPC Ouyi Pharmaceutical

YaoPharma

Venlafaxine Preparations Segment by Type

Capsules

Tablets

Venlafaxine Preparations Segment by Application

Generalized Anxiety Disorder

Social Anxiety Disorder and Panic Disorder

Depression

Other

Venlafaxine Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venlafaxine Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Venlafaxine Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venlafaxine Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Venlafaxine Preparations manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Venlafaxine Preparations by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Venlafaxine Preparations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Venlafaxine Preparations Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Venlafaxine Preparations Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Venlafaxine Preparations Sales Market Share by Manufacturers (2021-2026) Table 8. Global Venlafaxine Preparations Revenue of Manufacturers (2021-2026) Table 9. Global Venlafaxine Preparations Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Venlafaxine Preparations Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Venlafaxine Preparations Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Venlafaxine Preparations, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Venlafaxine Preparations, Product Type & Application Table 14. Global Venlafaxine Preparations Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Venlafaxine Preparations by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Alembic Company Information Table 19. Alembic Business Overview Table 20. Alembic Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Alembic Venlafaxine Preparations Product Portfolio Table 22. Alembic Recent Developments Table 23. Dr. Reddy's Laboratories Company Information Table 24. Dr. Reddy's Laboratories Business Overview Table 25. Dr. Reddy's Laboratories Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Dr. Reddy's Laboratories Venlafaxine Preparations Product Portfolio Table 27. Dr. Reddy's Laboratories Recent Developments Table 28. Granules Company Information Table 29. Granules Business Overview Table 30. Granules Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Granules Venlafaxine Preparations Product Portfolio Table 32. Granules Recent Developments Table 33. Macleods Pharmaceuticals Company Information Table 34. Macleods Pharmaceuticals Business Overview Table 35. Macleods Pharmaceuticals Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Macleods Pharmaceuticals Venlafaxine Preparations Product Portfolio Table 37. Macleods Pharmaceuticals Recent Developments Table 38. Orbion Pharmaceuticals Company Information Table 39. Orbion Pharmaceuticals Business Overview Table 40. Orbion Pharmaceuticals Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Orbion Pharmaceuticals Venlafaxine Preparations Product Portfolio Table 42. Orbion Pharmaceuticals Recent Developments Table 43. Pfizer Company Information Table 44. Pfizer Business Overview Table 45. Pfizer Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Pfizer Venlafaxine Preparations Product Portfolio Table 47. Pfizer Recent Developments Table 48. Teva Company Information Table 49. Teva Business Overview Table 50. Teva Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Teva Venlafaxine Preparations Product Portfolio Table 52. Teva Recent Developments Table 53. Zydus Company Information Table 54. Zydus Business Overview Table 55. Zydus Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Zydus Venlafaxine Preparations Product Portfolio Table 57. Zydus Recent Developments Table 58. Beijing Foyou Pharma Company Information Table 59. Beijing Foyou Pharma Business Overview Table 60. Beijing Foyou Pharma Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Beijing Foyou Pharma Venlafaxine Preparations Product Portfolio Table 62. Beijing Foyou Pharma Recent Developments Table 63. Changzhou Siyao Pharmaceuticals Company Information Table 64. Changzhou Siyao Pharmaceuticals Business Overview Table 65. Changzhou Siyao Pharmaceuticals Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Changzhou Siyao Pharmaceuticals Venlafaxine Preparations Product Portfolio Table 67. Changzhou Siyao Pharmaceuticals Recent Developments Table 68. Chengdu Brilliant Pharmaceutical Company Information Table 69. Chengdu Brilliant Pharmaceutical Business Overview Table 70. Chengdu Brilliant Pharmaceutical Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Chengdu Brilliant Pharmaceutical Venlafaxine Preparations Product Portfolio Table 72. Chengdu Brilliant Pharmaceutical Recent Developments Table 73. Chengdu Kanghong Pharmaceutical Company Information Table 74. Chengdu Kanghong Pharmaceutical Business Overview Table 75. Chengdu Kanghong Pharmaceutical Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Chengdu Kanghong Pharmaceutical Venlafaxine Preparations Product Portfolio Table 77. Chengdu Kanghong Pharmaceutical Recent Developments Table 78. ApicHope Pharmaceutical Company Information Table 79. ApicHope Pharmaceutical Business Overview Table 80. ApicHope Pharmaceutical Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. ApicHope Pharmaceutical Venlafaxine Preparations Product Portfolio Table 82. ApicHope Pharmaceutical Recent Developments Table 83. Sinopharm Group Company Information Table 84. Sinopharm Group Business Overview Table 85. Sinopharm Group Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sinopharm Group Venlafaxine Preparations Product Portfolio Table 87. Sinopharm Group Recent Developments Table 88. Hainan Herui Pharmaceutical Company Information Table 89. Hainan Herui Pharmaceutical Business Overview Table 90. Hainan Herui Pharmaceutical Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Hainan Herui Pharmaceutical Venlafaxine Preparations Product Portfolio Table 92. Hainan Herui Pharmaceutical Recent Developments Table 93. Hefei Lifeon Pharmaceutical Company Information Table 94. Hefei Lifeon Pharmaceutical Business Overview Table 95. Hefei Lifeon Pharmaceutical Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hefei Lifeon Pharmaceutical Venlafaxine Preparations Product Portfolio Table 97. Hefei Lifeon Pharmaceutical Recent Developments Table 98. Luye Pharma Company Information Table 99. Luye Pharma Business Overview Table 100. Luye Pharma Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Luye Pharma Venlafaxine Preparations Product Portfolio Table 102. Luye Pharma Recent Developments Table 103. CSPC Ouyi Pharmaceutical Company Information Table 104. CSPC Ouyi Pharmaceutical Business Overview Table 105. CSPC Ouyi Pharmaceutical Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. CSPC Ouyi Pharmaceutical Venlafaxine Preparations Product Portfolio Table 107. CSPC Ouyi Pharmaceutical Recent Developments Table 108. YaoPharma Company Information Table 109. YaoPharma Business Overview Table 110. YaoPharma Venlafaxine Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. YaoPharma Venlafaxine Preparations Product Portfolio Table 112. YaoPharma Recent Developments Table 113. Global Venlafaxine Preparations Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 114. Global Venlafaxine Preparations Sales by Region (2021-2026) & (K Units) Table 115. Global Venlafaxine Preparations Sales Market Share by Region (2021-2026) Table 116. Global Venlafaxine Preparations Sales by Region (2027-2032) & (K Units) Table 117. Global Venlafaxine Preparations Sales Market Share by Region (2027-2032) Table 118. Global Venlafaxine Preparations Revenue by Region (2021-2026) & (US$ Million) Table 119. Global Venlafaxine Preparations Revenue Market Share by Region (2021-2026) Table 120. Global Venlafaxine Preparations Revenue by Region (2027-2032) & (US$ Million) Table 121. Global Venlafaxine Preparations Revenue Market Share by Region (2027-2032) Table 122. North America Venlafaxine Preparations Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. North America Venlafaxine Preparations Sales by Country (2021-2026) & (K Units) Table 124. North America Venlafaxine Preparations Sales by Country (2027-2032) & (K Units) Table 125. North America Venlafaxine Preparations Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Venlafaxine Preparations Revenue by Country (2027-2032) & (US$ Million) Table 127. Europe Venlafaxine Preparations Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Europe Venlafaxine Preparations Sales by Country (2021-2026) & (K Units) Table 129. Europe Venlafaxine Preparations Sales by Country (2027-2032) & (K Units) Table 130. Europe Venlafaxine Preparations Revenue by Country (2021-2026) & (US$ Million) Table 131. Europe Venlafaxine Preparations Revenue by Country (2027-2032) & (US$ Million) Table 132. Asia Pacific Venlafaxine Preparations Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Asia Pacific Venlafaxine Preparations Sales by Country (2021-2026) & (K Units) Table 134. Asia Pacific Venlafaxine Preparations Sales by Country (2027-2032) & (K Units) Table 135. Asia Pacific Venlafaxine Preparations Revenue by Country (2021-2026) & (US$ Million) Table 136. Asia Pacific Venlafaxine Preparations Revenue by Country (2027-2032) & (US$ Million) Table 137. South America Venlafaxine Preparations Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. South America Venlafaxine Preparations Sales by Country (2021-2026) & (K Units) Table 139. South America Venlafaxine Preparations Sales by Country (2027-2032) & (K Units) Table 140. South America Venlafaxine Preparations Revenue by Country (2021-2026) & (US$ Million) Table 141. South America Venlafaxine Preparations Revenue by Country (2027-2032) & (US$ Million) Table 142. Middle East and Africa Venlafaxine Preparations Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Middle East and Africa Venlafaxine Preparations Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Venlafaxine Preparations Sales by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Venlafaxine Preparations Revenue by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Venlafaxine Preparations Revenue by Country (2027-2032) & (US$ Million) Table 147. Global Venlafaxine Preparations Sales by Type (2021-2026) & (K Units) Table 148. Global Venlafaxine Preparations Sales by Type (2027-2032) & (K Units) Table 149. Global Venlafaxine Preparations Sales Market Share by Type (2021-2026) Table 150. Global Venlafaxine Preparations Sales Market Share by Type (2027-2032) Table 151. Global Venlafaxine Preparations Revenue by Type (2021-2026) & (US$ Million) Table 152. Global Venlafaxine Preparations Revenue by Type (2027-2032) & (US$ Million) Table 153. Global Venlafaxine Preparations Revenue Market Share by Type (2021-2026) Table 154. Global Venlafaxine Preparations Revenue Market Share by Type (2027-2032) Table 155. Global Venlafaxine Preparations Price by Type (2021-2026) & (US$/Unit) Table 156. Global Venlafaxine Preparations Price by Type (2027-2032) & (US$/Unit) Table 157. Global Venlafaxine Preparations Sales by Application (2021-2026) & (K Units) Table 158. Global Venlafaxine Preparations Sales by Application (2027-2032) & (K Units) Table 159. Global Venlafaxine Preparations Sales Market Share by Application (2021-2026) Table 160. Global Venlafaxine Preparations Sales Market Share by Application (2027-2032) Table 161. Global Venlafaxine Preparations Revenue by Application (2021-2026) & (US$ Million) Table 162. Global Venlafaxine Preparations Revenue by Application (2027-2032) & (US$ Million) Table 163. Global Venlafaxine Preparations Revenue Market Share by Application (2021-2026) Table 164. Global Venlafaxine Preparations Revenue Market Share by Application (2027-2032) Table 165. Global Venlafaxine Preparations Price by Application (2021-2026) & (US$/Unit) Table 166. Global Venlafaxine Preparations Price by Application (2027-2032) & (US$/Unit) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Venlafaxine Preparations Distributors List Table 170. Venlafaxine Preparations Customers List Table 171. Venlafaxine Preparations Industry Trends Table 172. Venlafaxine Preparations Industry Drivers Table 173. Venlafaxine Preparations Industry Restraints Table 174. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Venlafaxine Preparations Product Image Figure 5. Global Venlafaxine Preparations Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Venlafaxine Preparations Market Size (2021-2032) & (US$ Million) Figure 7. Global Venlafaxine Preparations Sales (2021-2032) & (K Units) Figure 8. Global Venlafaxine Preparations Average Price (US$/Unit) & (2021-2032) Figure 9. Capsules Product Image Figure 10. Tablets Product Image Figure 11. Generalized Anxiety Disorder Product Image Figure 12. Social Anxiety Disorder and Panic Disorder Product Image Figure 13. Depression Product Image Figure 14. Other Product Image Figure 15. Global Venlafaxine Preparations Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Venlafaxine Preparations, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Venlafaxine Preparations Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Venlafaxine Preparations Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Venlafaxine Preparations Sales by Region in 2025 Figure 21. Global Venlafaxine Preparations Revenue by Region in 2025 Figure 22. North America Venlafaxine Preparations Market Size by Country in 2025 Figure 23. North America Venlafaxine Preparations Sales Market Share by Country (2021-2032) Figure 24. North America Venlafaxine Preparations Revenue Market Share by Country (2021-2032) Figure 25. United States Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Venlafaxine Preparations Market Size by Country in 2025 Figure 29. Europe Venlafaxine Preparations Sales Market Share by Country (2021-2032) Figure 30. Europe Venlafaxine Preparations Revenue Market Share by Country (2021-2032) Figure 31. Germany Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Venlafaxine Preparations Market Size by Country in 2025 Figure 42. Asia Pacific Venlafaxine Preparations Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Venlafaxine Preparations Revenue Market Share by Country (2021-2032) Figure 44. China Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Venlafaxine Preparations Market Size by Country in 2025 Figure 53. South America Venlafaxine Preparations Sales Market Share by Country (2021-2032) Figure 54. South America Venlafaxine Preparations Revenue Market Share by Country (2021-2032) Figure 55. Brazil Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Venlafaxine Preparations Market Size by Country in 2025 Figure 59. Middle East and Africa Venlafaxine Preparations Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Venlafaxine Preparations Revenue Market Share by Country (2021-2032) Figure 61. Egypt Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Venlafaxine Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Venlafaxine Preparations Sales Market Share by Type (2021-2032) Figure 67. Global Venlafaxine Preparations Revenue Market Share by Type (2021-2032) Figure 68. Global Venlafaxine Preparations Price (US$/Unit) by Type (2021-2032) Figure 69. Global Venlafaxine Preparations Sales Market Share by Application (2021-2032) Figure 70. Global Venlafaxine Preparations Revenue Market Share by Application (2021-2032) Figure 71. Global Venlafaxine Preparations Price (US$/Unit) by Application (2021-2032) Figure 72. Venlafaxine Preparations Value Chain Figure 73. Venlafaxine Preparations Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Venlafaxine Preparations Industry Opportunities and Challenges

Scope & coverage.

Types
  • Capsules
  • Tablets
Applications
  • Generalized Anxiety Disorder
  • Social Anxiety Disorder and Panic Disorder
  • Depression
  • Other
Companies covered
  • Alembic
  • Dr. Reddy's Laboratories
  • Granules
  • Macleods Pharmaceuticals
  • Orbion Pharmaceuticals
  • Pfizer
  • Teva
  • Zydus
  • Beijing Foyou Pharma
  • Changzhou Siyao Pharmaceuticals
  • Chengdu Brilliant Pharmaceutical
  • Chengdu Kanghong Pharmaceutical
  • ApicHope Pharmaceutical
  • Sinopharm Group
  • Hainan Herui Pharmaceutical
  • Hefei Lifeon Pharmaceutical
  • Luye Pharma
  • CSPC Ouyi Pharmaceutical
  • YaoPharma

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Venlafaxine Preparations Market Size (2021-2032)
  4. 2.2.2 Global Venlafaxine Preparations Sales (2021-2032)
  5. 2.2.3 Global Venlafaxine Preparations Market Average Price (2021-2032)
  6. 2.3 Venlafaxine Preparations by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Capsules
  9. 2.3.3 Tablets
  10. 2.4 Venlafaxine Preparations by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Generalized Anxiety Disorder
  13. 2.4.3 Social Anxiety Disorder and Panic Disorder
  14. 2.4.4 Depression
  15. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Venlafaxine Preparations Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Venlafaxine Preparations Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Venlafaxine Preparations Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Venlafaxine Preparations Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Venlafaxine Preparations Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Venlafaxine Preparations, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Venlafaxine Preparations, Product Type & Application
  8. 3.8 Global Manufacturers of Venlafaxine Preparations, Established Date
  9. 3.9 Global Venlafaxine Preparations Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Alembic
  2. 4.1.1 Alembic Company Information
  3. 4.1.2 Alembic Business Overview
  4. 4.1.3 Alembic Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Alembic Venlafaxine Preparations Product Portfolio
  6. 4.1.5 Alembic Recent Developments
  7. 4.2 Dr. Reddy's Laboratories
  8. 4.2.1 Dr. Reddy's Laboratories Company Information
  9. 4.2.2 Dr. Reddy's Laboratories Business Overview
  10. 4.2.3 Dr. Reddy's Laboratories Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Dr. Reddy's Laboratories Venlafaxine Preparations Product Portfolio
  12. 4.2.5 Dr. Reddy's Laboratories Recent Developments
  13. 4.3 Granules
  14. 4.3.1 Granules Company Information
  15. 4.3.2 Granules Business Overview
  16. 4.3.3 Granules Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Granules Venlafaxine Preparations Product Portfolio
  18. 4.3.5 Granules Recent Developments
  19. 4.4 Macleods Pharmaceuticals
  20. 4.4.1 Macleods Pharmaceuticals Company Information
  21. 4.4.2 Macleods Pharmaceuticals Business Overview
  22. 4.4.3 Macleods Pharmaceuticals Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Macleods Pharmaceuticals Venlafaxine Preparations Product Portfolio
  24. 4.4.5 Macleods Pharmaceuticals Recent Developments
  25. 4.5 Orbion Pharmaceuticals
  26. 4.5.1 Orbion Pharmaceuticals Company Information
  27. 4.5.2 Orbion Pharmaceuticals Business Overview
  28. 4.5.3 Orbion Pharmaceuticals Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Orbion Pharmaceuticals Venlafaxine Preparations Product Portfolio
  30. 4.5.5 Orbion Pharmaceuticals Recent Developments
  31. 4.6 Pfizer
  32. 4.6.1 Pfizer Company Information
  33. 4.6.2 Pfizer Business Overview
  34. 4.6.3 Pfizer Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pfizer Venlafaxine Preparations Product Portfolio
  36. 4.6.5 Pfizer Recent Developments
  37. 4.7 Teva
  38. 4.7.1 Teva Company Information
  39. 4.7.2 Teva Business Overview
  40. 4.7.3 Teva Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Teva Venlafaxine Preparations Product Portfolio
  42. 4.7.5 Teva Recent Developments
  43. 4.8 Zydus
  44. 4.8.1 Zydus Company Information
  45. 4.8.2 Zydus Business Overview
  46. 4.8.3 Zydus Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Zydus Venlafaxine Preparations Product Portfolio
  48. 4.8.5 Zydus Recent Developments
  49. 4.9 Beijing Foyou Pharma
  50. 4.9.1 Beijing Foyou Pharma Company Information
  51. 4.9.2 Beijing Foyou Pharma Business Overview
  52. 4.9.3 Beijing Foyou Pharma Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Beijing Foyou Pharma Venlafaxine Preparations Product Portfolio
  54. 4.9.5 Beijing Foyou Pharma Recent Developments
  55. 4.10 Changzhou Siyao Pharmaceuticals
  56. 4.10.1 Changzhou Siyao Pharmaceuticals Company Information
  57. 4.10.2 Changzhou Siyao Pharmaceuticals Business Overview
  58. 4.10.3 Changzhou Siyao Pharmaceuticals Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Changzhou Siyao Pharmaceuticals Venlafaxine Preparations Product Portfolio
  60. 4.10.5 Changzhou Siyao Pharmaceuticals Recent Developments
  61. 4.11 Chengdu Brilliant Pharmaceutical
  62. 4.11.1 Chengdu Brilliant Pharmaceutical Company Information
  63. 4.11.2 Chengdu Brilliant Pharmaceutical Business Overview
  64. 4.11.3 Chengdu Brilliant Pharmaceutical Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Chengdu Brilliant Pharmaceutical Venlafaxine Preparations Product Portfolio
  66. 4.11.5 Chengdu Brilliant Pharmaceutical Recent Developments
  67. 4.12 Chengdu Kanghong Pharmaceutical
  68. 4.12.1 Chengdu Kanghong Pharmaceutical Company Information
  69. 4.12.2 Chengdu Kanghong Pharmaceutical Business Overview
  70. 4.12.3 Chengdu Kanghong Pharmaceutical Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Chengdu Kanghong Pharmaceutical Venlafaxine Preparations Product Portfolio
  72. 4.12.5 Chengdu Kanghong Pharmaceutical Recent Developments
  73. 4.13 ApicHope Pharmaceutical
  74. 4.13.1 ApicHope Pharmaceutical Company Information
  75. 4.13.2 ApicHope Pharmaceutical Business Overview
  76. 4.13.3 ApicHope Pharmaceutical Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 ApicHope Pharmaceutical Venlafaxine Preparations Product Portfolio
  78. 4.13.5 ApicHope Pharmaceutical Recent Developments
  79. 4.14 Sinopharm Group
  80. 4.14.1 Sinopharm Group Company Information
  81. 4.14.2 Sinopharm Group Business Overview
  82. 4.14.3 Sinopharm Group Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Sinopharm Group Venlafaxine Preparations Product Portfolio
  84. 4.14.5 Sinopharm Group Recent Developments
  85. 4.15 Hainan Herui Pharmaceutical
  86. 4.15.1 Hainan Herui Pharmaceutical Company Information
  87. 4.15.2 Hainan Herui Pharmaceutical Business Overview
  88. 4.15.3 Hainan Herui Pharmaceutical Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Hainan Herui Pharmaceutical Venlafaxine Preparations Product Portfolio
  90. 4.15.5 Hainan Herui Pharmaceutical Recent Developments
  91. 4.16 Hefei Lifeon Pharmaceutical
  92. 4.16.1 Hefei Lifeon Pharmaceutical Company Information
  93. 4.16.2 Hefei Lifeon Pharmaceutical Business Overview
  94. 4.16.3 Hefei Lifeon Pharmaceutical Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Hefei Lifeon Pharmaceutical Venlafaxine Preparations Product Portfolio
  96. 4.16.5 Hefei Lifeon Pharmaceutical Recent Developments
  97. 4.17 Luye Pharma
  98. 4.17.1 Luye Pharma Company Information
  99. 4.17.2 Luye Pharma Business Overview
  100. 4.17.3 Luye Pharma Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Luye Pharma Venlafaxine Preparations Product Portfolio
  102. 4.17.5 Luye Pharma Recent Developments
  103. 4.18 CSPC Ouyi Pharmaceutical
  104. 4.18.1 CSPC Ouyi Pharmaceutical Company Information
  105. 4.18.2 CSPC Ouyi Pharmaceutical Business Overview
  106. 4.18.3 CSPC Ouyi Pharmaceutical Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 CSPC Ouyi Pharmaceutical Venlafaxine Preparations Product Portfolio
  108. 4.18.5 CSPC Ouyi Pharmaceutical Recent Developments
  109. 4.19 YaoPharma
  110. 4.19.1 YaoPharma Company Information
  111. 4.19.2 YaoPharma Business Overview
  112. 4.19.3 YaoPharma Venlafaxine Preparations Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 YaoPharma Venlafaxine Preparations Product Portfolio
  114. 4.19.5 YaoPharma Recent Developments
5 Global Venlafaxine Preparations Market Scenario by Region
  1. 5.1 Global Venlafaxine Preparations Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Venlafaxine Preparations Sales by Region: 2021-2032
  3. 5.2.1 Global Venlafaxine Preparations Sales by Region: 2021-2026
  4. 5.2.2 Global Venlafaxine Preparations Sales by Region: 2027-2032
  5. 5.3 Global Venlafaxine Preparations Revenue by Region: 2021-2032
  6. 5.3.1 Global Venlafaxine Preparations Revenue by Region: 2021-2026
  7. 5.3.2 Global Venlafaxine Preparations Revenue by Region: 2027-2032
  8. 5.4 North America Venlafaxine Preparations Market Facts & Figures by Country
  9. 5.4.1 North America Venlafaxine Preparations Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Venlafaxine Preparations Sales by Country (2021-2032)
  11. 5.4.3 North America Venlafaxine Preparations Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Venlafaxine Preparations Market Facts & Figures by Country
  16. 5.5.1 Europe Venlafaxine Preparations Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Venlafaxine Preparations Sales by Country (2021-2032)
  18. 5.5.3 Europe Venlafaxine Preparations Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Venlafaxine Preparations Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Venlafaxine Preparations Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Venlafaxine Preparations Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Venlafaxine Preparations Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Venlafaxine Preparations Market Facts & Figures by Country
  41. 5.7.1 South America Venlafaxine Preparations Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Venlafaxine Preparations Sales by Country (2021-2032)
  43. 5.7.3 South America Venlafaxine Preparations Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Venlafaxine Preparations Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Venlafaxine Preparations Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Venlafaxine Preparations Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Venlafaxine Preparations Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Venlafaxine Preparations Sales by Type (2021-2032)
  2. 6.1.1 Global Venlafaxine Preparations Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Venlafaxine Preparations Sales Market Share by Type (2021-2032)
  4. 6.2 Global Venlafaxine Preparations Revenue by Type (2021-2032)
  5. 6.2.1 Global Venlafaxine Preparations Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Venlafaxine Preparations Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Venlafaxine Preparations Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Venlafaxine Preparations Sales by Application (2021-2032)
  2. 7.1.1 Global Venlafaxine Preparations Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Venlafaxine Preparations Sales Market Share by Application (2021-2032)
  4. 7.2 Global Venlafaxine Preparations Revenue by Application (2021-2032)
  5. 7.2.1 Global Venlafaxine Preparations Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Venlafaxine Preparations Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Venlafaxine Preparations Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Venlafaxine Preparations Value Chain Analysis
  2. 8.1.1 Venlafaxine Preparations Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Venlafaxine Preparations Production Mode & Process
  5. 8.2 Venlafaxine Preparations Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Venlafaxine Preparations Distributors
  8. 8.2.3 Venlafaxine Preparations Customers
9 Global Venlafaxine Preparations Analyzing Market Dynamics
  1. 9.1 Venlafaxine Preparations Industry Trends
  2. 9.2 Venlafaxine Preparations Industry Drivers
  3. 9.3 Venlafaxine Preparations Industry Opportunities and Challenges
  4. 9.4 Venlafaxine Preparations Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst